HM Payson & Co’s Mesa Laboratories MLAB Stock Holding History

HM Payson & Co’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5	Closed	-$1K	–	1112
2021 Q2	$1K	Buy	+5	New	+$1.27K	﹤0.01%	1058

Other funds holding MLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

HM Payson & Co's MLAB Position: Q3 2021 in Review

HM Payson & Co sold out of Mesa Laboratories (MLAB) in Q3 2021, closing a stake of 5 shares — an estimated $1K sold.

HM Payson & Co first reported a position in MLAB in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 172 funds tracked by Wall St. Rank hold MLAB as of Q3 2021.

HM Payson & Co reported no remaining Mesa Laboratories position as of Q3 2021 after selling out during the quarter.
HM Payson & Co sold 5 Mesa Laboratories shares in Q3 2021, an estimated $1K.
HM Payson & Co first reported a position in Mesa Laboratories in Q2 2021 and held it in 1 quarter.
HM Payson & Co's Mesa Laboratories position peaked at $1K in Q2 2021.
172 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2021.

Based on HM Payson & Co's 13F filing for Q3 2021, filed 30 Nov 2021.